Valuation: Quest Laboratories Limited

Market Cap 1.48B 15.72M 14.29M 13.21M 11.93M 22.48M 23.34M 159M 62.89M 792M 58.98M 57.75M 2.51B P/E 2025
12.4x
P/E 2026 11.5x
Enterprise Value 1.43B 15.25M 13.87M 12.81M 11.57M 21.81M 22.65M 154M 61.02M 769M 57.22M 56.02M 2.43B EV / Sales 2025
1.43x
EV / Sales 2026 1.49x
Free-Float
99%
Yield 2025 *
-
Yield 2026 -
1 day-0.99%
1 week+6.25%
Current month+9.88%
1 month-4.15%
3 months-1.48%
6 months-21.72%
Current year-18.17%
1 week 80.05
Extreme 80.05
92.9
1 month 80.05
Extreme 80.05
92.9
Current year 68.6
Extreme 68.6
152.6
1 year 68.6
Extreme 68.6
152.6
3 years 68.6
Extreme 68.6
196.8
5 years 68.6
Extreme 68.6
196.8
10 years 68.6
Extreme 68.6
196.8
Manager TitleAgeSince
Chief Executive Officer 59 2023-12-31
Director of Finance/CFO 38 2023-12-31
Compliance Officer - 2025-09-02
Director TitleAgeSince
Chairman 59 2023-12-31
Director/Board Member 31 2021-03-04
Director/Board Member 73 2024-01-09
Change 5-day change 1-year change 3-year change Capi.($)
-0.99%+6.25%+3.21% - 15.82M
-0.82%+5.74%+39.64%+143.26% 1,286B
-1.12%+2.29%+44.21%+89.89% 688B
-0.16%+1.11%+26.76%+114.06% 521B
+1.14%+4.87%+43.06%+71.97% 386B
-2.23%-1.55%+55.47%+42.54% 364B
+1.27%+2.01%+30.01%+62.35% 302B
+0.37%+0.75%+3.71%+39.09% 287B
-0.72%+0.41%+37.29%+69.33% 252B
-0.30%+0.41%+34.04%+123.32% 208B
Average -0.12%+2.60%+31.74%+83.98% 429B
Weighted average by Cap. -0.23%+3.26%+36.97%+98.27%

Financials

2025 2026
Net sales 1.04B 11.07M 10.06M 9.3M 8.4M 15.83M 16.44M 112M 44.28M 558M 41.53M 40.66M 1.77B 1.12B 11.91M 10.82M 10M 9.03M 17.02M 17.68M 120M 47.63M 600M 44.67M 43.73M 1.9B
Net income 136M 1.44M 1.31M 1.21M 1.1M 2.07M 2.14M 14.57M 5.78M 72.81M 5.42M 5.31M 230M 149M 1.58M 1.44M 1.33M 1.2M 2.26M 2.35M 15.97M 6.33M 79.81M 5.94M 5.82M 253M
Net Debt -191M -2.03M -1.85M -1.71M -1.54M -2.9M -3.02M -20.5M -8.13M -102M -7.62M -7.46M -324M -44M -469K -426K -394K -356K -670K -696K -4.73M -1.87M -23.62M -1.76M -1.72M -74.73M
Projected Income Statement - Annual - Quest Laboratories Limited
Logo Quest Laboratories Limited
Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.
Employees
99
Date Price Change Volume
26-11-16 ₹90.10 -0.99% 14,400
26-11-13 ₹91.00 -2.05% 6,000
26-11-12 ₹92.90 +3.22% 6,000
26-11-11 ₹90.00 +4.29% 15,600
  1. Stock Market
  2. Stocks
  3. QUESTLAB Stock